Clariant AG (CLN.VX)

CLN.VX on Virt-X Level 1

17.06CHF
4:43am EDT
Price Change (% chg)

CHF-0.26 (-1.50%)
Prev Close
CHF17.32
Open
CHF17.33
Day's High
CHF17.34
Day's Low
CHF16.94
Volume
720,198
Avg. Vol
1,457,371
52-wk High
CHF18.83
52-wk Low
CHF14.22

CLN.VX

Chart for CLN.VX

About

Clariant AG is a Switzerland-based specialty chemicals company. Its products and services are grouped into four business areas: Care Chemicals, Catalysis & Energy, Natural Resources, and Plastics & Coatings. The Company develops, produces, markets and sells specialty chemical products for various end markets such as specialty... (more)

Overall

Beta: 1.73
Market Cap (Mil.): CHF5,749.19
Shares Outstanding (Mil.): 331.94
Dividend: 0.36
Yield (%): 2.08

Financials

  CLN.VX Industry Sector
P/E (TTM): 24.48 24.38 39.19
EPS (TTM): 0.71 -- --
ROI: 4.13 7.11 14.98
ROE: 8.29 9.73 17.30
Search Stocks

BRIEF-Clariant posts Q2 sales of 1.531 billion SFR

July 30 - Clariant AG : * Says Q2 sales of 1.531 billion SFR (versus average f'cast of 1.519 billion

1:13am EDT

UPDATE 1-Clariant swings to first quarter loss, sales steady

ZURICH, April 30 - Swiss specialty chemicals maker Clariant AG swung to a first-quarter loss of 48 million Swiss francs ($54 million) due to a 84 million franc charge to divest its ASK Chemicals joint venture.

30 Apr 2014

Clariant swings to first quarter loss, sales steady

ZURICH, April 30 - Swiss speciality chemicals maker Clariant swung to a first-quarter loss of 48 million Swiss francs ($54 million) due to a 84 million franc charge to divest its ASK Chemicals joint venture.

30 Apr 2014

Clariant, Ashland to sell German joint venture ASK Chemicals

ZURICH, April 9 - Swiss chemicals company Clariant and U.S. chemical manufacturer Ashland Inc said they had agreed to sell their joint venture ASK Chemicals to funds affiliated with private equity investment firm Rhone.

09 Apr 2014

Clariant Q4 net profit flat on forex, higher spending

ZURICH, Feb 19 - Clariant said its fourth-quarter net profit was virtually unchanged from a year earlier, as currency swings and higher spending hit.

19 Feb 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks